Current Computer-Aided Drug Design
Volume 18, 7 Issues, 2022
ISSN: 1875-6697 (Online)
ISSN: 1573-4099 (Print)
This journal supports open access
ISSN: 1875-6697 (Online)
ISSN: 1573-4099 (Print)
This journal supports open access
Contents
Current Computer-Aided Drug Design , Volume 16 - Number 6
Research Article
Modeling Physico-Chemical Properties of Quinolone Derivatives Using GA-MLR as a Computational Study
, 16(6): 667 - 681Meysam Shirmohammadi, Esmat Mohammadinasab* and Zakiyeh Bayat
DOI: 10.2174/1573409915666191212152439
Research Article
2D- and 3D-QSAR Modeling of Imidazole-Based Glutaminyl Cyclase Inhibitors
, 16(6): 682 - 697Omar Husham Ahmed Al-Attraqchi and Katharigatta N. Venugopala*
DOI: 10.2174/1573409915666190918150136
Research Article
Interactions of Flavone and Steroid from A. subintegra as Potential Inhibitors for Porcine Pancreatic Lipase
, 16(6): 698 - 706Mastura Ibrahim, Saripah Salbiah Syed Abdul Azziz*, Chee Fah Wong*, Yuhanis Mhd Bakri and Fauziah Abdullah
DOI: 10.2174/1573409915666191015112320
Research Article
Research Article
Development of 'S', 'N' Heterocycles as Antimycobacterials Targeting Fatty Acid Biosynthesis
, 16(6): 718 - 724Lalita K. Dahiwade*, Sneha P. Rochlani, Prafulla B. Choudhari, Rakesh P. Dhavale and Harinath N. More
DOI: 10.2174/1573409915666191017150843
Research Article
Identification of Key Features of CNS Drugs Based on SVM and Greedy Algorithm
, 16(6): 725 - 733Ruilin Zhang and Yanrui Ding*
DOI: 10.2174/1573409915666191212095340
Research Article
Multi-Targeted Design and Development of Dihydroisoquinolines as Potent Antimalarials
, 16(6): 734 - 740Raviraj V. Mule*, Sneha P. Rochlani, Prafulla B. Choudhari, Rakesh P. Dhavale and Manish S. Bhatia
DOI: 10.2174/1573409915666191017145833
Research Article
Virtual Screening-Based Discovery of Potent Hypoglycemic Agents: In Silico, Chemical Synthesis and Biological Study
, 16(6): 741 - 756Mohammed A. Khedr *, Omar M. M. Mohafez and Ibrahim A. Al-Haider
DOI: 10.2174/1573409915666191018121558
Research Article
Design, Synthesis and In vitro Biological Activity of Some New 1,3- thiazolidine-4-one Derivatives as Chemotherapeutic Agents using Virtual Screening Strategies
, 16(6): 757 - 771Pragya Nayak* and Monica Kachroo
DOI: 10.2174/1573409916666200116102359
Research Article
Research Article
A New Class of Coumate Benzimidazole Hybrids as BRCA 1 Mimetics Through Unconventional Binding Mode; Synthesis and Preliminary Cytotoxicity Screening
, 16(6): 786 - 801Selvaraj Jubie*, Shyam Sundar, Neetu Yadav, Podila Naresh, Ashish Wadhwani and Jawahar Natarajan
DOI: 10.2174/1573409916666191231102046
Research Article
Synthesis, SAR, In silico Appraisal and Anti-Microbial Study of Substituted 2-aminobenzothiazoles Derivatives
, 16(6): 802 - 813Devidas G. Anuse, Suraj N. Mali, Bapu R. Thorat*, Ramesh S. Yamgar and Hemchandra K. Chaudhari
DOI: 10.2174/1573409915666191210125647
Research Article
Combined High Throughput Screening with QSAR Analysis Unravelling Potential Glyoxalase-I Inhibitors
, 16(6): 814 - 832Mahmoud A. Al-Sha’er*, Qosay A. Al-Balas and Mohammad A. Hassan
DOI: 10.2174/1573409916666200117100326
Research Article
Acknowledgement
Editor-in-Chief
Dong-Qing Wei
(11801 citations)
State Key Laboratory of Microbial Metabolism and College of Life Sciences and Biotechnology
Shanghai Jiao Tong University
Shanghai
(China)
Biography
(11801 citations)
State Key Laboratory of Microbial Metabolism and College of Life Sciences and Biotechnology
Shanghai Jiao Tong University
Shanghai
Biography
Biography of Dong-Qing Wei
Dr. Dong-Qing Wei is a Professor at College of Life Science, Shanghai Jiaotong University, China. Over the past 40 decades, he has made many great contributions to the development of bioinformatics/AI drug design techniques and their interdisciplinary applications to systems of ever-increasing complexity. His most important contributions in sciences are exemplified by the discovery of ferroelectric nematic liquids crystals, elucidating the molecular mechanism of explosion reactions by the ab initio MD simulation, and discovery of anti-aging and anti-AD drug candidate WGX-50. He has published more than 600 papers, 10 monographs with 11000 SCI citations. He has attended more than 100 conferences for plenary talks and have organized more than 20 national and international conferences.
About the Journal
⇨ Journal Home⇨ Editorial Policies⇨ Fabricating and Stating False Information⇨ Research Misconduct⇨ Post Publication Discussions and Corrections⇨ Allegations from Whistleblowers⇨ Editorial Board⇨ Meet the Executive Guest Editor(s)⇨ Board Recruitment Workflow⇨ Short Guide⇨ Join Editorial Board⇨ Indexing Information⇨ Announcements⇨ Endorsements⇨ Authors' Comments
For Authors
For Librarians & Readers
Quick Links
Advertisement
Webmaster Contact: info@benthamscience.net